Evaluation of neoadjuvant chemotherapy with modified FOLFOX6 (Combination chemotherapy of infusional 5-FU/I-Leucovorin and intermittent Oxaliplatin) with Bevacizumab/ Cetuximab in patients with advanced lower rectal cancer
Evaluation of neoadjuvant chemotherapy with modified FOLFOX6 (Combination chemotherapy of infusional 5-FU/I-Leucovorin and intermittent Oxaliplatin) with Bevacizumab/ Cetuximab in patients with advanced lower rectal cancer
复制标题
改良FOLFOX6（输注5-FU/I-亚叶酸和间歇奥沙利铂联合化疗）联合贝伐珠单抗/西妥昔单抗治疗晚期下位直肠癌的评价
DOI：
--
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Miyazawa Y
中科院分区：
文献类型：
--
作者：
Kosugi C;Koda K;Shimizu H;Yamazaki M;Shuto K;Nojima H;Hosokawa I;Murakami T;Takhashi M;Miyazawa Y
